Answer

Caution is strongly advised; you should not take Ginkgo with Digoxin without close medical supervision. Ginkgo may increase the plasma concentrations of Digoxin, potentially leading to digoxin toxicity.

Evidence Assessment

Overall Evidence Strength: Limited (Tier C) The assessment is based on pharmacokinetic data regarding P-glycoprotein (P-gp) inhibition. While systematic reviews of herbal-drug interactions exist [PMID:19719333], the specific interaction between Ginkgo and Digoxin is primarily derived from mechanistic data (cyp-inferred) rather than large-scale clinical trials.

Clinical Evidence

The interaction between Ginkgo and Digoxin is mediated by the P-glycoprotein (P-gp) efflux transporter. Ginkgo acts as a moderate inhibitor of P-gp. Because Digoxin is a substrate of P-gp, the inhibition of this transporter decreases the clearance and metabolism of the drug, which can lead to increased plasma levels of Digoxin in the bloodstream.

Elevated levels of Digoxin are clinically significant due to the drug's narrow therapeutic index, meaning a small increase in concentration can lead to toxicity. Symptoms of digoxin toxicity may include nausea, vomiting, visual disturbances (such as yellow-green halos), and cardiac arrhythmias.

Practical Guidance

If a patient is currently taking Digoxin and wishes to start Ginkgo, the following guidelines apply: * Population: This interaction is particularly dangerous for elderly patients or those with renal impairment, as they already have a decreased clearance of Digoxin. * Monitoring: Patients must be monitored for signs of digoxin toxicity. * Dosing: A reduction in the Digoxin dose may be necessary if Ginkgo supplementation is continued. * Alternative: Consider an alternative supplement that does not inhibit P-gp if the goal is cognitive support.

Safety & Interactions

Contraindication: Caution / High Risk

• Drug Class/Mechanism: P-gp inhibitor (Ginkgo) interacting with a P-gp substrate (Digoxin).
• Clinical Management: If combined, healthcare providers should perform more frequent monitoring of serum digoxin levels. Immediate discontinuation of Ginkgo is recommended if signs of toxicity appear.
• High-Risk Populations:
  • CKD (Chronic Kidney Disease): High risk due to reduced renal excretion of Digoxin.
  • Elderly: Increased risk of toxicity due to age-related decline in organ function.
  • Liver Disease: Potential for altered metabolism of herbal constituents.

Consult a healthcare provider before combining these substances to ensure safe dosing and monitoring.